Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling

• Michele Zanoni,
• Henrique Borges da Silva,
• Elena Adinolfi

Affiliations

Michele Zanoni

Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Henrique Borges da Silva

Department of Immunology, Mayo Clinic, Scottsdale, AZ, United States

Elena Adinolfi

Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, Ferrara, Italy